German experience in the management of ELGAN infants

German experience in the management of ELGAN infants

Authors

  • Hans Fuchs Neonatology and Ped. Intensive Care, Center for Pediatrics, University of Freiburg, Germany

Keywords:

surfactant, sustained lung inflation

Abstract

Of 680 000 infants born in Germany a year roughly 10% are preterm and 1% are very preterm. They are treated in around 150 level 1 perinatal centers and there are various credos how to best treat the ELGAN infant. However, many centers include the use of a sustained inflation for lung aeration in the standard protocol of delivery room care in Germany. As a result of the large studies on delivery room care, a trend for earlier or prophylactic surfactant in the most immature infants can be observed, however, surfactant is increasingly given in a new less invasive way called LISA. German randomized controlled trials on LISA , on permissive hypercapnia in the premature infants and a German initiated European trial on inhaled steroids have been completed and preliminary results are available. NIRS so far mostly is used for research reasons; however, the number of centers that monitor brain oxygenation for clinical reasons to guide hemodynamic management is increasing. A recent initiative was able to tremendously reduce the rate of IVH by prospective multidisciplinary surveillance.

Downloads

Published

29-06-2015

How to Cite

1.
Fuchs H. German experience in the management of ELGAN infants. Acta Biomed [Internet]. 2015 Jun. 29 [cited 2024 Jul. 27];86(1S):16-20. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/4538